DEA Can’t get Past FDA

In any situation it is important to take a look at all sides before forming an opinion. While it is often justified and certainly easy to point fingers at the DEA for their reluctance to reschedule cannabis, it is crucial to note the other organizations with power over cannabis. The FDA is a major stopping point for the DEA and Leafly’s recent article The Accepted Medical Use of Marijuana: States Need to Take Action Now to Protect Patient Rights explains in further depth how they are connected.